Advancing human ovarian biology in tandem with clinical care: considerations for collecting ovarian tissue for research after oophorectomy for tissue cryopreservation - Report - MDSpire

Advancing human ovarian biology in tandem with clinical care: considerations for collecting ovarian tissue for research after oophorectomy for tissue cryopreservation

  • By

  • Margaret A. Brunette

  • Karen Burns

  • Holly Hoefgen

  • Shuo Xiao

  • Francesca E. Duncan

  • Monica M. Laronda

  • Ariella Shikanov

  • Mary Zelinski

  • Veronica Gomez-Lobo

  • June 3, 2026

  • 0 min

Share

Clinical Report: Enhancing Understanding of Ovarian Biology Through Clinical Practice

Overview

This report discusses the significance of ovarian tissue collection post-oophorectomy for cryopreservation research, highlighting the importance of informed consent and systematic tissue collection methods.

Background

Ovarian tissue cryopreservation (OTC) has been recognized as a non-experimental fertility preservation method since 2019, allowing for the collection of research tissue samples from healthy premenopausal patients. These samples, along with demographic and hormonal data, provide insights into ovarian function and reproductive health.

Data Highlights

No numerical data available in the source material.

Key Findings

['OTC is no longer considered experimental and is endorsed for fertility preservation.', 'Informed consent must clearly outline the use of ovarian tissue for research and patient rights.', 'Most sites have shifted from small biopsies to unilateral oophorectomy for tissue collection.', 'Documentation of the tissue collection site is crucial for consistent evaluation across studies.', 'Research tissue processing methods can limit the types of analyses available.']

Clinical Implications

Clinicians must ensure that informed consent for ovarian tissue collection is comprehensive and transparent.

Conclusion

The collection of ovarian tissue for research purposes requires careful consideration of consent and collection methods.

Related Resources & Content

  1. American Society for Reproductive Medicine, ASRM, 2026 -- Fertility preservation in patients with medical indications: a committee opinion
  2. Fertility Preservation in People With Cancer: ASCO Guideline Update - PubMed
  3. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025 - PMC
  4. The ASCO Post — SIDEBAR: Oocyte Preservation
  5. The ASCO Post — Options for Preserving Fertility Should Be Considered Early to Maximize the Likelihood of Success
  6. Frontiers in Endocrinology — Ethical considerations and management strategies for fertility preservation in women of reproductive age with malignant tumors: Chinese practices and perspectives
  7. Frontiers in Endocrinology — Editorial: Advancing reproductive outcomes: integrating molecular, metabolic, and endocrine insights into oocyte maturation
  8. Oocyte Preservation - The ASCO Post
  9. Options for Preserving Fertility Should Be Considered Early - The ASCO Post
  10. Fertility preservation in patients with medical indications: a committee opinion (2026) | American Society for Reproductive Medicine | ASRM
  11. Fertility Preservation in People With Cancer: ASCO Guideline Update - PubMed
  12. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025 - PMC
  13. 1 ESHRE recommendations on Good 1 Practice in
  14. Comparison of the quality of ovarian tissue cryopreservation by conventional slow cryopreservation and vitrification—a systematic review and meta-analysis | Journal of Ovarian Research | Springer Nature Link
  15. Perinatal outcomes of pregnancies following autologous cryopreserved ovarian tissue transplantation: a systematic review with pooled analysis - PMC
  16. 45 CFR § 46.116 - General requirements for informed consent. | Electronic Code of Federal Regulations (e-CFR) | US Law | LII / Legal Information Institute
  17. Best Practices for Biospecimen Resources - NCI

Original Source(s)

Related Content